Mubagwa K, Carmeliet E
Arch Int Pharmacodyn Ther. 1987 Mar;286(1):71-84.
The influence of the organic calcium channel blockers D600 and verapamil on cardiac cholinergic effects was studied using standard electrophysiological techniques on rabbit atrial strips, and using the two-microelectrode voltage-clamp technique on rabbit Purkinje fibers. The interaction between the above drugs as well as between AQA-39, diltiazem or nifedipine and muscarinic receptors was investigated using tritiated quinuclidinylbenzilate ([3H]QNB) binding on rabbit atrial homogenates. The electrophysiological experiments show that D600 and verapamil, at high concentrations (greater than 10(-6) M), inhibit the hyperpolarization and the increase in K+ conductance induced by acetylcholine. The binding experiments show that this inhibitory action of Ca2+ antagonists is due to an interaction at the level of muscarinic receptors. All the Ca2+ channel blockers used, except nifedipine, behave like classical muscarinic antagonists as shown by a 1 to 1 reaction between drug and receptor molecules. Because of the low affinity for the interaction between the Ca2+ channel blockers and muscarinic receptors, the clinical importance of this antimuscarinic effect is probably negligible.
采用标准电生理技术,在兔心房肌条上研究了有机钙通道阻滞剂D600和维拉帕米对心脏胆碱能效应的影响;并采用双微电极电压钳技术,在兔浦肯野纤维上进行了此项研究。运用氚化喹核醇基苯甲酸酯([3H]QNB)与兔心房匀浆结合的方法,研究了上述药物之间以及AQA-39、地尔硫䓬或硝苯地平与毒蕈碱受体之间的相互作用。电生理实验表明,高浓度(大于10⁻⁶ M)的D600和维拉帕米可抑制乙酰胆碱诱导的超极化和钾离子电导增加。结合实验表明,钙拮抗剂的这种抑制作用是由于在毒蕈碱受体水平上的相互作用。除硝苯地平外,所有使用的钙通道阻滞剂均表现为典型的毒蕈碱拮抗剂,药物与受体分子之间呈1:1反应。由于钙通道阻滞剂与毒蕈碱受体相互作用的亲和力较低,这种抗毒蕈碱效应的临床重要性可能微不足道。